Prospective study of exclusive strontium-/yttrium-90 beta-irradiation of primary and recurrent pterygia with no prior surgical excision. Clinical outcome of long-term follow-up

Vastardis, Iraklis; Pajic, Bojan; Greiner, Richard H; Pajic-Eggspuehler, Brigitte; Aebersold, Daniel M (2009). Prospective study of exclusive strontium-/yttrium-90 beta-irradiation of primary and recurrent pterygia with no prior surgical excision. Clinical outcome of long-term follow-up. Strahlentherapie und Onkologie, 185(12), pp. 808-14. Heidelberg: Springer-Medizin-Verlag 10.1007/s00066-009-2000-1

[img]
Preview
Text
s00066-009-2000-1.pdf - Published Version
Available under License Publisher holds Copyright.

Download (479kB) | Preview

PURPOSE: To evaluate the consecutive treatment results regarding pterygium recurrence and the efficacy of exclusive strontium-/yttrium-90 beta-irradiation for primary and recurrent pterygia and to analyze the functional outcome. PATIENTS AND METHODS: Between October 1974 and December 2005, 58 primary and 21 recurrent pterygia were exclusively treated with strontium-/yttrium-90 beta-irradiation with doses ranging from 3,600 to 5,500 cGy. The follow-up time was 46.6 +/- 26.7 months, with a median of 46.5 months. RESULTS: The treatment led to a size reduction in all pterygia (p < 0.0001). Neither recurrences nor side effects were observed during therapy and follow-up in this study. Best-corrected visual acuity increased (p = 0.0064). Corneal astigmatism was reduced in recurrent pterygia (p = 0.009). CONCLUSION: Exclusive strontium-/yttrium-90 beta-irradiation of pterygia is a very efficient and well-tolerated treatment, with remarkable aesthetic and rehabilitative results in comparison to conventional treatments, especially for recurrent lesions which have undergone prior surgical excision.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology

UniBE Contributor:

Aebersold, Daniel Matthias

ISSN:

0179-7158

Publisher:

Springer-Medizin-Verlag

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 15:12

Last Modified:

02 Mar 2023 23:23

Publisher DOI:

10.1007/s00066-009-2000-1

PubMed ID:

20013090

Web of Science ID:

000272525100005

BORIS DOI:

10.48350/31639

URI:

https://boris.unibe.ch/id/eprint/31639 (FactScience: 196282)

Actions (login required)

Edit item Edit item
Provide Feedback